HD-OPM Archive
Topics › Inflammation & CRP

Meta-analysis: statins, bempedoic acid, ezetimibe and omega-3 lower CRP independent of LDL

Gokhan Can · Feb 19, 2024 · ♥ 11 reactions · 3 comments · original Facebook post
Inflammation & CRPPCSK9, ezetimibe & newer drugs
AI summary & key facts

Highlights a Cardiovascular Research meta-analysis of RCTs showing that statins, bempedoic acid, ezetimibe and omega-3 fatty acids significantly reduce CRP, independent of how much they lower LDL-C. The author adds a list of other anti-inflammatory options to consider, such as colchicine and GLP-1 RAs.

Effect of lipid-lowering therapies on C-reactive protein levels: a comprehensive meta-analysis of randomized controlled trials

"Statins, bempedoic acid, ezetimibe, and omega-3 FAs significantly reduce serum CRP concentration, independently of LDL-C reductions."

Paper · Cardiovasc Res · 2024Effect of lipid-lowering therapies on C-reactive protein levels: a comprehensive meta-analysis of randomized controlled trials.Chronic low-degree inflammation is a hallmark of atherosclerotic cardiovascular (CV) disease. To assess the effect of lipid-lowering therapies on C-reactive protein (CRP), a biomarker of inflammation, we conducted a meta-analysis according to the PRISMA guidelines. Databases were searched from inception to July 2023. Inclusion criteria were: (i) randomized controlled trials (RCTs) in human, Phase II, III, or IV;…academic.oup.com

PS: Also consider Colchicine, GLP1-RA, low dose pioglitazone, curcumin, 4 herb synergy, milk thistle...

Research cited

#bempedoicacid#omega3#statins#ezetimibe#protein#colchicine#glp1#pioglitazone
← newer: Group reaches 600 membersolder: Niacin breakdown products 2PY and 4PY linked to higher cardi →